Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 2, 2011, Pages 108-116

  Carter, Tonia C ^a   Olney, Richard S ^b   Mitchell, Allen A ^c   Romitti, Paul A ^d   Bell, Erin M ^e   Druschel, Charlotte M ^e,f  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Chlamydia; Congenital abnormalities; Female genital diseases; Gonorrhea; Herpes genitalis

Indexed keywords

ADULT; ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CHILD; CHLAMYDIASIS; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; GENITAL TRACT INFECTION; GONORRHEA; HUMAN; INTERVIEW; KIDNEY AGENESIS; KIDNEY HYPOPLASIA; LIMB DEFECT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PRIORITY JOURNAL; RISK; SELF REPORT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CLEFT LIP; CLEFT PALATE; CONGENITAL ABNORMALITIES; FEMALE; GENITAL DISEASES, FEMALE; GONORRHEA; HUMANS; INFANT, NEWBORN; KIDNEY; LIMB DEFORMITIES, CONGENITAL; ODDS RATIO; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; RISK; SELF REPORT;

CHLAMYDIA; HERPES;

EID: 79851478247     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20749     Document Type: Article

References (52)

1. Acs N, Bánhidy F, Puhó EH, et al. 2008a. No association between vulvovaginitis-bacterial vaginosis, related drug treatments of pregnant women, and congenital abnormalities in their offspring - a population-based case-control study. Cent Eur J Med 3: 332-340.
2. Acs N, Bánhidy F, Puhó E, Czeizel AE. 2008b. No association between maternal recurrent genital herpes in pregnancy and higher risk for congenital abnormalities. Acta Obstet Gynecol Scand 87: 292-299.
3. Acs N, Bánhidy F, Puhó E, Czeizel AE. 2008c. Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 82: 563-570.
4. Allsworth JE, Ratner JA, Peipert JF. 2009. Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 36: 738-744.
5. Bánhidy F, Acs N, Puhó EH, Czeizel AE. 2010. Birth outcomes among pregnant women with genital warts. Int J Gynaecol Obstet 108: 153-154.
6. Banura C, Franceschi S, van Doorn L, et al. 2008. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int J Cancer 123: 2180-2187.
7. Botto LD, Lin AE, Riehle-Colarusso T, et al. 2007. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79: 714-727.
8. Brown ZA, Selke S, Zeh J, et al. 1997. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337: 509-515.
9. Carmichael SL, Shaw GM, Iovannisci DM, et al. 2006. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am J Med Genet A 140: 2433-2440.
10. Caro-Patón T, Carvajal A, Martin de Diego I, et al. 1997. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 44: 179-182.
11. Carter TC, Druschel CM, Romitti PA, et al. 2008. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol 198: 191.e1-191.e7.
12. Castellsagué X, Drudis T, Cañadas MP, et al. 2009. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis 9: 74.
13. Chow JM, Yonekura ML, Richwald GA, et al. 1990. The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA 263: 3164-3167.
14. Cogswell ME, Bitsko RH, Anderka M, et al. 2009. Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol 170: 975-985.
15. Collier SA, Rasmussen SA, Feldkamp ML, et al. 2009. Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 85: 193-201.
16. Cotch MF, Pastorek JG, 2nd, Nugent RP, et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24: 353-360.
17. Crider KS, Cleves MA, Reefhuis J, et al. 2009. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163: 978-985.
18. De Francesco MA, Gargiulo F, Negrini R, et al. 2008. Different sequence strains of Streptococcus agalactiae elicit various levels of cytokine production. Immunol Invest 37: 741-751.
19. Feldkamp ML, Reefhuis J, Kucik J, et al. 2008. Case-control study of self reported genitourinary infections and risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2003. BMJ 336: 1420-1423.
20. French JI, McGregor JA, Parker R. 2006. Readily treatable reproductive tract infections and preterm birth among black women. Am J Obstet Gynecol 194: 1717-1726; discussion 1726-1727.
21. Gencay M, Koskiniemi M, Ammülü P, et al. 2000. Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS 108: 584-588.
22. Govender S, Theron GB, Odendaal HJ, Chalkley LJ. 2009. Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy. J Obstet Gynaecol 29: 698-701.
23. Greenland S. 2007. Bayesian perspectives for epidemiological research. II. Regression analysis. Int J Epidemiol 36: 195-202.
24. Hiltunen-Back E, Haikala O, Kautiainen H, et al. 2001. A nationwide sentinel clinic survey of chlamydia trachomatis infection in Finland. Sex Transm Dis 28: 252-258.
25. Hutto C, Arvin A, Jacobs R, et al. 1987. Intrauterine herpes simplex virus infections. J Pediatr 110: 97-101.
26. Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. [No authors listed] 1989. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery. Am J Epidemiol 129: 1247-1257.
27. Johansson AB, Rassart A, Blum D, et al. 2004. Lower-limb hypoplasia due to intrauterine infection with herpes simplex virus type 2: possible confusion with intrauterine varicella-zoster syndrome. Clin Infect Dis 38: e57-e62.
28. Johnson HL, Erbelding EJ, Zenilman JM, Ghanem KG. 2007. Sexually transmitted diseases and risk behaviors among pregnant women attending inner city public sexually transmitted diseases clinics in Baltimore, MD, 1996-2002 Sex Transm Dis 34: 991-994.
29. Kimberlin DW, Lin CY, Jacobs RF, et al. 2001. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108: 223-229.
30. Meis PJ, Goldenberg RL, Mercer B, et al. 1995. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 173: 1231-1235.
31. Métneki J, Puhó E, Czeizel AE. 2005. Maternal diseases and isolated orofacial clefts in Hungary. Birth Defects Res A Clin Mol Teratol 73: 617-623.
32. Miller JMJr, Maupin RT, Mestad RE, Nsuami M. 2003. Initial and repeated screening for gonorrhea during pregnancy. Sex Transm Dis 30: 728-730.
33. Minkoff H, Grunebaum AN, Schwarz RH, et al. 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 150: 965-972.
34. MRC Vitamin Study Research Group. [No authors listed] 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
35. Norgård B, Nørgaard M, Czeizel AE, et al. 2006. Maternal herpes labialis in pregnancy and neural tube defects. Dev Med Child Neurol 48: 674-676.
36. Queisser-Luft A, Stolz G, Wiesel A, et al. 2002. Malformations in newborn: results based on 30, 940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 266: 163-167.
37. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
38. Rastogi S, Salhan S, Mittal A. 2000. Detection of Chlamydia trachomatis antigen in spontaneous abortions. Is this organism a primary or secondary indicator of risk? Br J Biomed Sci 57: 126-129.
39. Reiff-Eldridge R, Heffner CR, Ephross SA, et al. 2000. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 182(1 Pt 1): 159-163.
40. Schuchat A, Oxtoby M, Cochi S, et al. 1990. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 162: 672-677.
41. South MA, Tompkins WA, Morris CR, Rawls WE. 1969. Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr 75: 13-18.
42. Stone KM, Reiff-Eldridge R, White AD, et al. 2004. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 70: 201-207.
43. Thorsen P, Vogel I, Molsted K, et al. 2006. Risk factors for bacterial vaginosis in pregnancy: a population-based study on Danish women. Acta Obstet Gynecol Scand 85: 906-911.
44. Tolosa JE, Chaithongwongwatthana S, Daly S, et al. 2006. The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynecol 195: 1198-1204.
45. Valkenberg-van den Berg AW, Sprij AJ, Oostvogel PM, et al. 2006. Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol 124: 178-183.
46. Vats V, Agrawal T, Salhan S, Mittal A. 2007. Primary and secondary immune responses of mucosal and peripheral lymphocytes during Chlamydia trachomatis infection. FEMS Immunol Med Microbiol 49: 280-287.
47. Vogt G, Puhó E, Czeizel AE, et al. 2005. Population-based case-control study of isolated congenital cataract. Birth Defects Res A Clin Mol Teratol 73: 997-1005.
48. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161: 745-750.
49. Werden J, Schnatz PF, Mandavilli S, et al. 2008. Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests. J Low Genit Tract Dis 12: 287-292.
50. Wiesenfeld HC, Sweet RL, Ness RB, et al. 2005. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 32: 400-405.
51. World Health Organization Task Force on the Prevention and Management of Infertility. [No authors listed] 1995. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 22: 71-77.
52. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116 Suppl 1: 32-40.